NCT04097613 (Betadine) is a EARLY_PHASE1 clinical trial of Povidone-Iodine in Chronic Rhinosinusitis (Diagnosis), sponsored by St. Paul's Hospital, Canada.

Who is sponsoring NCT04097613?

NCT04097613 is sponsored by St. Paul's Hospital, Canada.

What drugs are being tested in NCT04097613?

Interventions in NCT04097613: Povidone-Iodine, Budesonide.

What condition does NCT04097613 study?

NCT04097613 studies Chronic Rhinosinusitis (Diagnosis).

Is NCT04097613 still recruiting?

NCT04097613 is currently completed. Last updated 20 September 2019.

Last reviewed 2019-09-20 · How we verify

NCT04097613: Betadine

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort Study

Completed EARLY_PHASE1 Last updated 20 September 2019

What this trial tests

EARLY_PHASE1 trial testing Povidone-Iodine in Chronic Rhinosinusitis (Diagnosis) in 29 participants. Completed in 31 August 2019.

Timeline

28 July 2017

Primary endpoint
1 April 2019

31 August 2019

Quick facts

Lead sponsor	St. Paul's Hospital, Canada
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	29
Start date	28 July 2017
Primary completion	1 April 2019
Estimated completion	31 August 2019
Sites	1 location across Canada

Drugs / interventions tested

Povidone-Iodine — full drug profile →
Budesonide (BUDESONIDE) — full drug profile →

Conditions studied

Chronic Rhinosinusitis (Diagnosis) — all drugs for Chronic Rhinosinusitis (Diagnosis) →

Sponsor

St. Paul's Hospital, Canada

Who can join

19 and older, any sex, with Chronic Rhinosinusitis (Diagnosis). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Povidone Iodine solution is a nasal antiseptic. Its application has been shown to be clinically safe, tolerable and effective against bacteria and fungi associated with chronic rhinosinusitis. This study will evaluate the effectiveness of Povidone Iodine in this hard-to-treat patient group. Furthermore, the study will also further evaluate any side effects that may occur with the use of Povidone Iodine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Povidone-Iodine

Trials testing the same drug.

NCT07044726 — Betadine vs Sterile Water for Periurethral Preparation · Phase 4 · not yet recruiting
NCT07460297 — Pseudomonas Aeruginosa Injection Combined With Polyvinylpyrrolidone-Iodine in Immediate Breast Reconstruction Surgery Wi · NA · enrolling by invitation
NCT06667089 — Povidone-Iodine Versus Chlorhexidine in Surgical Wound Care · NA · completed
NCT05919888 — SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty · Phase 4 · completed
NCT05895773 — Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia · Phase 2, PHASE3 · completed

Other recruiting trials for Chronic Rhinosinusitis (Diagnosis)

Currently open trials in the same condition.

NCT05427695 — Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis · Phase 2 · recruiting
NCT06986629 — Effect of Photobiostimulation Versus Pulsed Electromagnetic Field on Quality of Life in Adults With Chronic Rhinosinusit · NA · recruiting
NCT05882903 — The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis · Phase 2 · recruiting
NCT05857228 — Viral and Epigenetic Influences in CRSwNP · active not recruiting
NCT04670172 — Real-Life Chronic Rhinosinusitis Outcome Registry · recruiting

Other St. Paul's Hospital, Canada trials

Trials by the same sponsor.

NCT06750302 — Effectiveness of Penthrox vs Placebo in Sinus Procedures, a Clinical Trial · Phase 1, PHASE2 · recruiting
NCT06570590 — Prospective Study of Minimally Invasive Lapidus Procedure for Hallux Valgus Deformities · NA · not yet recruiting
NCT05006287 — The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery · Phase 2 · active not recruiting
NCT04476628 — Efficacy of Budesonide Via Delayed Release vs Immediate Release · EARLY_PHASE1 · withdrawn
NCT04449965 — Povidone-Iodine Rinses in the Management of COVID-19 · EARLY_PHASE1 · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04097613 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Paul's Hospital, Canada
Last refreshed: 20 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04097613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing